Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.190
+0.060 (5.31%)
Nov 6, 2024, 4:00 PM EST - Market closed
Neuronetics Employees
Neuronetics had 203 employees as of December 31, 2023. The number of employees increased by 9 or 4.64% compared to the previous year.
Employees
203
Change (1Y)
9
Growth (1Y)
4.64%
Revenue / Employee
$355,000
Profits / Employee
-$159,966
Market Cap
36.05M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ProPhase Labs | 113 |
Beyond Air | 107 |
Adagio Medical Holdings | 85 |
NextCure | 82 |
BioLineRx | 79 |
SAB Biotherapeutics | 57 |
Curis | 49 |
Lumos Pharma | 33 |
STIM News
- 8 days ago - Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call - GlobeNewsWire
- 24 days ago - NeuroStar® Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression - GlobeNewsWire
- 4 weeks ago - Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings - PRNewsWire
- 6 weeks ago - Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents - GlobeNewsWire
- 7 weeks ago - Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults - GlobeNewsWire
- 7 weeks ago - NeuroStar® Releases Software Upgrades to Elevate Patient Care - GlobeNewsWire
- 2 months ago - NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories - GlobeNewsWire
- 3 months ago - Neuronetics, Inc. (STIM) Q2 2024 Earnings Call Transcript - Seeking Alpha